These bile acids not only showed anti-inflammatory properties in in vivo RA model (63), but can also regulate bone metabolism through the activation of the bile acid membrane receptor TGR5, which decreases osteoclast differentiation both in in vitro and in vivo settings (64). The gene discussed is GPBAR1; the disease is rheumatoid arthritis.